Attenuation of cocaine's reinforcing and discriminative stimulus effects via muscarinic M1 acetylcholine receptor stimulation

Journal of Pharmacology and Experimental Therapeutics

Volumn 332, Issue 3, 2010, Pages 959-969

  Thomsen, Morgane ^a   Conn, P Jeffrey ^b   Lindsley, Craig ^b   Wess, Jürgen ^c   Boon, Joon Y ^a   Fulton, Brian S ^a,e   Fink Jensen, Anders ^d   Caine, S Barak ^a  

^a MCLEAN HOSPITAL   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d Mental Health Services CPH   (Denmark)

^e NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ((1 2 METHYLBENZYL) 1,4 BIPIPERIDIN 4 YL) 1H BENZO[D]IMIDAZOL 2(3H) ONE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; AMPHETAMINE; METHYLSCOPOLAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M1 RECEPTOR AGONIST; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC M4 RECEPTOR; OXOTREMORINE; PILOCARPINE; SCOPOLAMINE; SODIUM CHLORIDE; UNCLASSIFIED DRUG; XANOMELINE;

ANIMAL EXPERIMENT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG EFFECT; DRUG SELECTIVITY; ENZYME ACTIVATION; FEEDING BEHAVIOR; MALE; MODULATION; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; TASK PERFORMANCE;

ALLOSTERIC REGULATION; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; COCAINE-RELATED DISORDERS; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DOPAMINE ANTAGONISTS; LIGANDS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCARINIC AGONISTS; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M4; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 77249154757     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.162057     Document Type: Article

References (43)

1. Acri JB, Siedleck BK, and Witkin JM (1996) Effects of benztropine on behavioral and toxic effects of cocaine: comparison with atropine and the selective dopamine uptake inhibitor 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl- propyl)-piperazine. J Pharmacol Exp Ther 277:198-206.
2. Alderson HL, Latimer MP, Blaha CD, Phillips AG, and Winn P (2004) An examination of d-amphetamine self-administration in pedunculopontine tegmental nucleus-lesioned rats. Neuroscience 125:349-358.
3. Bechara A and van der Kooy D (1989) The tegmental pedunculopontine nucleus: a brain-stem output of the limbic system critical for the conditioned place preferences produced by morphine and amphetamine. J Neurosci 9:3400-3409.
4. Blaha CD, Allen LF, Das S, Inglis WL, Latimer MP, Vincent SR, and Winn P (1996) Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine tegmental nucleus-lesioned, and laterodorsal tegmental nucleus-lesioned rats. J Neurosci 16:714-722.
5. Burt DR, Enna SJ, Creese I, and Snyder SH (1975) Dopamine receptor binding in the corpus striatum of mammalian brain. Proc Natl Acad Sci U S A 72:4655-4659.
6. Bymaster FP, Shannon HE, Rasmussen K, Delapp NW, Mitch CH, Ward JS, Calligaro DO, Ludvigsen TS, Sheardown MJ, Olesen PH, et al. (1998) Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1] octane. Eur J Pharmacol 356: 109-119.
7. Caine SB, Negus SS, Mello NK, Patel S, Bristow L, Kulagowski J, Vallone D, Saiardi A, and Borrelli E (2002) Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists. J Neurosci 22:2977-2988.
8. Carrigan KA and Dykstra LA (2007) Behavioral effects of morphine and cocaine in M1 muscarinic acetylcholine receptor-deficient mice. Psychopharmacology (Berl) 191:985-993.
9. Chapman CA, Yeomans JS, Blaha CD, and Blackburn JR (1997) Increased striatal dopamine efflux follows scopolamine administered systemically or to the tegmental pedunculopontine nucleus. Neuroscience 76:177-186.
10. Crespo JA, Sturm K, Saria A, and Zernig G (2006) Activation of muscarinic and nicotinic acetylcholine receptors in the nucleus accumbens core is necessary for the acquisition of drug reinforcement. J Neurosci 26:6004-6010.
11. Dewey SL, Smith GS, Logan J, Brodie JD, Simkowitz P, MacGregor RR, Fowler JS, Volkow ND, and Wolf AP (1993) Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. Proc Natl Acad Sci U S A 90:11816-11820.
12. Di Chiara G, Morelli M, and Consolo S (1994) Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci 17: 228-233.
13. Eglen RM (2006) Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function. Auton Autacoid Pharmacol 26:219-233.
14. Fagergren P, Overstreet DH, Goiny M, and Hurd YL (2005) Blunted response to cocaine in the Flinders hypercholinergic animal model of depression. Neuroscience 132:1159-1171.
15. Forster GL, Yeomans JS, Takeuchi J, and Blaha CD (2002) M5 muscarinic receptors are required for prolonged accumbal dopamine release after electrical stimulation of the pons in mice. J Neurosci 22:RC190.
16. Gomeza J, Zhang L, Kostenis E, Felder C, Bymaster F, Brodkin J, Shannon H, Xia B, Deng C, and Wess J (1999) Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci U S A 96:10483-10488.
17. Grasing K, He S, and Yang Y (2009) Long-lasting decreases in cocaine-reinforced behavior following treatment with the cholinesterase inhibitor tacrine in rats selectively bred for drug self-administration. Pharmacol Biochem Behav 94:169-178.
18. Hardouin SN, Richmond KN, Zimmerman A, Hamilton SE, Feigl EO, and Nathanson NM (2002) Altered cardiovascular responses in mice lacking the M(1) muscarinic acetylcholine receptor. J Pharmacol Exp Ther 301:129-137.
19. Hikida T, Kitabatake Y, Pastan I, and Nakanishi S (2003) Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc Natl Acad Sci U S A 100:6169-6173.
20. Ikemoto S and Wise RA (2002) Rewarding effects of the cholinergic agents carbachol and neostigmine in the posterior ventral tegmental area. J Neurosci 22:9895-9904.
21. Jones CK, Brady AE, Davis AA, Xiang Z, Bubser M, Tantawy MN, Kane AS, Bridges TM, Kennedy JP, Bradley SR, et al. (2008) Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats. J Neurosci 28:10422-10433.
22. Kane BE, Grant MK, El-Fakahany EE, and Ferguson DM (2008) Synthesis and evaluation of xanomeline analogs - probing the wash-resistant phenomenon at the M1 muscarinic acetylcholine receptor. Bioorg Med Chem 16:1376-1392.
23. Katz JL, Izenwasser S, Kline RH, Allen AC, and Newman AH (1999) Novel 3alpha-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine. J Pharmacol Exp Ther 288:302-315.
24. Kremin T, Gerber D, Giocomo LM, Huang SY, Tonegawa S, and Hasselmo ME (2006) Muscarinic suppression in stratum radiatum of CA1 shows dependence on presynaptic M1 receptors and is not dependent on effects at GABA(B) receptors. Neurobiol Learn Mem 85:153-163.
25. Leiber D, Marc S, and Harbon S (1990) Pharmacological evidence for distinct muscarinic receptor subtypes coupled to the inhibition of adenylate cyclase and to the increased generation of inositol phosphates in the guinea pig myometrium. J Pharmacol Exp Ther 252:800-809.
26. Mark GP, Kinney AE, Grubb MC, Zhu X, Finn DA, Mader SL, Berger SP, and Bechtholt AJ (2006) Injection of oxotremorine in nucleus accumbens shell reduces cocaine but not food self-administration in rats. Brain Res 1123:51-59.
27. Miyakawa T, Yamada M, Duttaroy A, and Wess J (2001) Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J Neurosci 21:5239-5250.
28. Oakman SA, Faris PL, Kerr PE, Cozzari C, and Hartman BK (1995) Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to ventral tegmental area. J Neurosci 15:5859-5869.
29. Onali P and Olianas MC (2002) Muscarinic M4 receptor inhibition of dopamine D1-like receptor signalling in rat nucleus accumbens. Eur J Pharmacol 448:105-111.
30. Ranaldi R and Woolverton WL (2002) Self-administration of cocaine: scopolamine combinations by rhesus monkeys. Psychopharmacology (Berl) 161:442-448.
31. Rasmussen T, Sauerberg P, Nielsen EB, Swedberg MD, Thomsen C, Sheardown MJ, Jeppesen L, Calligaro DO, DeLapp NW, Whitesitt C, et al. (2000) Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive mice. Eur J Pharmacol 402:241-246.
32. Roberts DC, Koob GF, Klonoff P, and Fibiger HC (1980) Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol Biochem Behav 12:781-787.
33. Schmidt LS, Miller AD, Lester DB, Bay-Richter C, Schulein C, Frikke-Schmidt H, Wess J, Blaha CD, Woldbye DP, Fink-Jensen A, et al. (2010) Increased amphetamine-induced locomotor activity, sensitization, and accumbal dopamine release in M(5) muscarinic receptor knockout mice. Psychopharmacology (Berl), 207:547-558.
34. Shannon HE, Bymaster FP, Calligaro DO, Greenwood B, Mitch CH, Sawyer BD, Ward JS, Wong DT, Olesen PH, and Sheardown MJ (1994) Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors. J Pharmacol Exp Ther 269:271-281.
35. Smith JE, Co C, Yin X, Sizemore GM, Liguori A, Johnson WE III, and Martin TJ (2004) Involvement of cholinergic neuronal systems in intravenous cocaine selfadministration. Neurosci Biobehav Rev 27:841-850.
36. Spealman RD (1996) Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 278:1128-1137.
37. Tanda G, Ebbs AL, Kopajtic TA, Elias LM, Campbell BL, Newman AH, and Katz JL (2007) Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats. J Pharmacol Exp Ther 321:334-344.
38. Tanda G and Katz JL (2007) Muscarinic preferential M(1) receptor antagonists enhance the discriminative-stimulus effects of cocaine in rats. Pharmacol Biochem Behav 87:400-404.
39. Thomsen M and Caine SB (2005) Chronic intravenous drug self-administration in rats and mice, in Current Protocols of Neuroscience, Chapter 9: Preclinical Models of Neurologic and Psychiatric Disorders, unit 9.20, Wiley, Hoboken, NJ.
40. 5 acetylcholine receptordeficient mice. J Neurosci 25:8141-8149.
41. Walland A, Palluk R, Burkard S, and Hammer R (1997) Compensation of muscarinic bronchial effects of talsaclidine by concomitant sympathetic activation in guinea pigs. Eur J Pharmacol 330:213-219.
42. Wilson MC and Schuster CR (1973) Cholinergic influence on intravenous cocaine self-administration by rhesus monkeys. Pharmacol Biochem Behav 1:643-649.
43. You ZB, Wang B, Zitzman D, and Wise RA (2008) Acetylcholine release in the mesocorticolimbic dopamine system during cocaine seeking: conditioned and unconditioned contributions to reward and motivation. J Neurosci 28:9021-9029.